Shangya Technology Co., Ltd. (TPEX:6130)
22.80
-0.15 (-0.65%)
Jun 3, 2026, 1:30 PM CST
Shangya Technology Market Cap
Shangya Technology has a market cap or net worth of 1.01 billion as of June 3, 2026. Its market cap has decreased by -27.39% in one year.
Market Cap
1.01B
Enterprise Value
1.08B
Revenue
154.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.80
Market Cap Chart
Since November 3, 2004, Shangya Technology's market cap has increased from 885.72M to 1.01B, an increase of 14.04%. That is a compound annual growth rate of 0.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 1.01B | -48.76% |
| Dec 31, 2025 | 1.97B | 88.96% |
| Dec 31, 2024 | 1.04B | -31.54% |
| Dec 29, 2023 | 1.52B | 15.05% |
| Dec 30, 2022 | 1.32B | -7.53% |
| Dec 30, 2021 | 1.43B | 117.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 335.21B |
| Caliway Biopharmaceuticals | 150.66B |
| Lotus Pharmaceutical | 51.51B |
| Heron Neutron Medical | 51.35B |
| GeneReach Biotechnology | 1.04B |
| Concord Medical | 1.02B |
| Lukas Biomedical | 1.01B |
| Wiltrom | 1.01B |